Patents/Assignees

Merck Sharp & Dohme Corp.

12 patents in portfolio

US12291570utility2025
Treatment of Metastatic Pancreatic Adenocarcinoma
0 cites
US12059461utility2024
Methods for Making Polysaccharide-protein Conjugates
0 cites
US11925709utility2024
Tablet Formulation for CGRP Active Compounds
0 cites
US11767292utility2023
Process for Making Beta 3 Agonists and Intermediates
0 cites
US11738010utility2023
Oxazolidinones as Taro Inhibitors
0 cites
US11708371utility2023
Process for Making Beta 3 Agonists and Intermediates
0 cites
US11673877utility2023
Niraparib Compositions
0 cites
US11649243utility2023
Process for Preparing Beta 3 Agonists and Intermediates
0 cites
US11545270utility2023
Dossier Change Control Management System
0 cites
US8343990utility2013
Substituted Cyclopropyl Compounds, Compositions Containing Such Compounds and Methods of Treatment
0 cites
US8344114utility2013
Antagonists of PCSK9
0 cites
US8344144utility2013
Inhibitors of Janus Kinases
0 cites